Harbor Capital Advisors’s 89bio ETNB Stock Holding History

Harbor Capital Advisors’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-57,706	Closed	-$848K	–	1342
2025 Q3	$848K	Sell	57,706 -160,046	-73%	-$1.63M	0.07%	358
2025 Q2	$2.14M	Sell	217,752 -97,020	-31%	-$803K	0.09%	283
2025 Q1	$2.29M	Buy	314,772 +62,874	+25%	+$550K	0.1%	264
2024 Q4	$1.97M	Buy	251,898 +23,968	+11%	+$197K	0.09%	289
2024 Q3	$1.69M	Buy	227,930 +142,032	+165%	+$1.19M	0.07%	348
2024 Q2	$688K	Buy	85,898 +61,641	+254%	+$550K	0.05%	449
2024 Q1	$282K	Buy	24,257 +19,498	+410%	+$216K	0.04%	538
2023 Q4	$53.2K	Sell	4,759 -977	-17%	-$8.98K	0.01%	435
2023 Q3	$88.6K	Sell	5,736 -637	-10%	-$10.7K	0.02%	422
2023 Q2	$121K	Sell	6,373 -114	-2%	-$2K	0.02%	417
2023 Q1	$98.8K	Buy	+6,487	New	+$84.6K	0.03%	239

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbor Capital Advisors's ETNB Position: Q4 2025 in Review

Harbor Capital Advisors sold out of 89bio (ETNB) in Q4 2025, closing a stake of 57,706 shares — an estimated $848K sold.

Harbor Capital Advisors first reported a position in ETNB in Q1 2023 and held it in 11 quarters. The position peaked at $2.29M in Q1 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Harbor Capital Advisors reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Harbor Capital Advisors sold 57,706 89bio shares in Q4 2025, an estimated $848K.
Harbor Capital Advisors first reported a position in 89bio in Q1 2023 and held it in 11 quarters.
Harbor Capital Advisors's 89bio position peaked at $2.29M in Q1 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Harbor Capital Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.